Abstract:
Background: Deep vein catheterization is common in patients with advanced cancer, but safety and cost comparisons between catheter types are limited.
Purpose: To evaluate the safety and economic impact of a modified medium-length catheter versus a standard peripherally inserted central catheter (PICC) line in patients with advanced cancer.
Methods: A prospective cohort study was conducted involving 160 patients with advanced cancer receiving palliative care between January 2022 and April 2024. Patients were randomized to a study group (modified medium-length catheter) or control group (PICC line). Venous complications, satisfaction, and costs were compared.
Results: The study group had lower rates of venous thrombosis, bleeding, and catheter infection. Patient satisfaction and costs were also significantly better in the study group.
Conclusions: The modified medium-length catheter provides better safety, higher satisfaction, and reduced costs, making it a preferred option for patients with advanced cancer.
Reference:Yu Y, Zhou Q, Ye G, Yan J, Chen Y, Wang B. Safety and Cost Evaluation of Modified Medium-Length Catheters in Patients With Advanced Cancer: A Randomized Controlled Trial. J Nurs Care Qual. 2025 Aug 12. doi: 10.1097/NCQ.0000000000000905. Epub ahead of print. PMID: 40839805.